Clinical trial
The Safety and Effectiveness of Warfarin Vs Apixaban in Patients With Non-Valvular Atrial Fibrillation/ Venous Thromboembolism and End-Stage Kidney Disease on Dialysis
NCT06606275 is registered in ClinicalTrials.gov with Abu Dhabi Health Services Company as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Safety and Effectiveness of Warfarin Vs Apixaban in Patients With Non-Valvular Atrial Fibrillation/ Venous Thromboembolism and End-Stage Kidney Disease on Dialysis
- Lead sponsor
- Abu Dhabi Health Services Company
- Phase
- Observational
- Overall status
- Completed
- Start date
- January 1, 2024
- Completion date
- November 5, 2024
- Enrollment
- 67 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
end-stage kidney disease (eskd), non-valvular atrial fibrillation (nvaf), venous thromboembolism (vte)